This study is in progress, not accepting new patients
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Century Therapeutics, Inc.
- ID
- NCT05336409
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- About 28 people participating
- Last Updated